Indivior Pharmaceuticals (INDV) Shares Outstanding (2021 - 2026)

Indivior Pharmaceuticals has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $118.0 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 5.41% year-over-year to $118.0 million in Q2 2026; TTM through Jun 2026 was $118.0 million, a 5.41% decrease from a year earlier, with the FY2025 full-year figure at $125.1 million, changed 0.33% from the prior year.
• Shares Outstanding (Entity) was $118.0 million for Q2 2026 at Indivior Pharmaceuticals, down from $121.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $136.5 million in Q4 2023, with the low at $118.0 million in Q2 2026.
• Average Shares Outstanding (Entity) over 5 years is $128.3 million, with a median of $125.0 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) dropped 8.69% in 2024, then climbed 0.33% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $136.5 million in 2022, then rose by 0.03% to $136.5 million in 2023, then decreased by 8.69% to $124.7 million in 2024, then increased by 0.33% to $125.1 million in 2025, then slipped by 5.64% to $118.0 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $118.0 million (Q2 2026), $121.9 million (Q1 2026), and $125.1 million (Q4 2025), per Business Quant data.